Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
Clinical trial NCT03870880 · COMPLETED
Trial details
- NCT number
- NCT03870880
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-25
- Primary completion
- 2020-01-08
- Enrollment
- 215
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.